Author

David L. Mayhew

Foghorn Therapeutics (United States)ORCID 0000-0001-9127-0548Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Assay:ChIP-seq· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Asad M. TaherbhoyiD· 1 shared Brenna Sherbanee· 1 shared David L. LahriD· 1 shared Lionel ChiaiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Asad M. TaherbhoyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cell BiologybioRxivPreprintDec 18, 2023

Hijacking the transcriptional activation potential of the BAF complex via Induced Proximity

Lionel Chia, David L. Mayhew, Brenna Sherbanee…·Asad M. Taherbhoy

This study uses induced proximity to redirect BAF complexes to activate therapeutic genes, altering chromatin landscapes and identifying proliferation-suppressing genes.

2 citations

humanChIP-seq

𝕏 PostBluesky